Shionogi joins CMAC as a Tier 1 Partner
Shionogi, a leading Japanese pharmaceutical company, has joined the CMAC consortium, marking a pivotal step in global collaboration and innovation.
New centre of excellence for regulation to accelerate digital adoption to ensure faster and safer delivery of medicines to patients
A new £1m research project to realise the transformative potential of digital technologies like artificial intelligence (AI) in medicines development and manufacturing has been announced.
The Centre of Excellence in Regulatory Science and Innovation (CERSI) project aims to advance regulatory processes by integrating cutting-edge digital technologies.
Sanofi Joins CMAC as Tier 1 Partner, Fostering Research & Innovation in Advanced Pharmaceutical Development & Manufacturing
This collaboration marks a significant milestone for the Centre in driving collaborative research and innovation within advanced pharmaceutical manufacturing.